TFF Pharmaceuticals Inc. (TFFP) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results
May 14, 2020 4:04 PM EDTMaintains clinical progress with lead programs, Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder
Thin Film Freezing platform technology employed in numerous partnership programs for vaccine and anti-viral applications
Conference call and live webcast scheduled for Thursday, May 14, 2020 at 5:00pm EDT
AUSTIN, Texas--(BUSINESS WIRE)--
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today reported financial results... More
